APA (7th ed.) Citation

Duarte, C., Abbott, D., McMahon, C. M., Kent, A., Schwartz, M., Gutman, J., . . . Amaya, M. L. (2024). Access to Novel Therapies Impacts Overall Survival (OS) in Low Socioeconomic (SES) Acute Myeloid Leukemia (AML) Patients (Pts). Blood, 144(Supplement 1), 3803. https://doi.org/10.1182/blood-2024-201061

Chicago Style (17th ed.) Citation

Duarte, Cassandra, Diana Abbott, Christine M. McMahon, Andrew Kent, Marc Schwartz, Jonathan Gutman, Daniel A. Pollyea, and Maria L. Amaya. "Access to Novel Therapies Impacts Overall Survival (OS) in Low Socioeconomic (SES) Acute Myeloid Leukemia (AML) Patients (Pts)." Blood 144, no. Supplement 1 (2024): 3803. https://doi.org/10.1182/blood-2024-201061.

MLA (9th ed.) Citation

Duarte, Cassandra, et al. "Access to Novel Therapies Impacts Overall Survival (OS) in Low Socioeconomic (SES) Acute Myeloid Leukemia (AML) Patients (Pts)." Blood, vol. 144, no. Supplement 1, 2024, p. 3803, https://doi.org/10.1182/blood-2024-201061.